Raloxifene: all 46 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the BrainRecruitingNCT07470606Phase 2
- New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic HyperplasiaRecruitingNCT06944145Phase 2
- Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.CompletedNCT05172050Phase 2/3Results posted
- Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian SyndromeTerminatedNCT01607320Not applicableResults posted
- Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?CompletedNCT01166958Phase 4Results posted
- Nutritional Supplements and Hormonal Manipulations for Breast Cancer PreventionCompletedNCT00723398Not applicableResults posted
- Cognition in the Study of Tamoxifen and RaloxifeneCompletedNCT00687102Phase 3Results posted
- Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral DensityCompletedNCT00431444Phase 4Results posted
- Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian SyndromeCompletedNCT00427700Phase 3Results posted
- Raloxifene for Women With Alzheimer's DiseaseCompletedNCT00368459Phase 2Results posted
- Raloxifene and Rimostil for Perimenopause-Related DepressionCompletedNCT00030147Phase 4Results posted
- Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With OsteopeniaCompletedNCT05386784Phase 4
- Comparative Antiresorptive Efficacy Discontinuation of DenosumabActive, not recruitingNCT03623633Phase 4
- Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in WomenCompletedNCT03418831Phase 4
- Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryWithdrawnNCT03147196Phase 2
- Raloxifene Augmentation in Patients With a Schizophrenia Spectrum DisorderCompletedNCT03043820Phase 3
- Osteoporosis Treatment in Post-menopausal WomenStatus unknownNCT03006003Phase 4
- Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid ArthritisCompletedNCT02982083Not applicable
- A Drug-drug Interaction Study of DP-R213CompletedNCT02654093Phase 1
- Selective Estrogen Receptor Modulators for Women of Child-bearing Age With SchizophreniaCompletedNCT02354001Phase 4
- Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal WomenCompletedNCT01573637Phase 3
- Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal OsteoporosisCompletedNCT01544894Phase 4
- Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal OsteoporosisCompletedNCT01535027Phase 4
- Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?CompletedNCT01481883Phase 4
- Raloxifene in Treatment of Schizophrenia and Schizoaffective DisorderStatus unknownNCT01280305Phase 3
- Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate CancerCompletedNCT01050842Early Phase 1
- Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal WomenCompletedNCT01041092Phase 4
- Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00670319Phase 3
- Long Term Effects of Raloxifene Treatment on Bone QualityCompletedNCT00532428Phase 4
- Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or PlaceboCompletedNCT00532246Phase 4
- Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid TherapyCompletedNCT00371956Phase 4
- Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of SchizophreniaCompletedNCT00361543Phase 4
- Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral EstrogenCompletedNCT00332553Phase 2
- 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal OsteoporosisCompletedNCT00191425Phase 4
- Raloxifene Use for The HeartCompletedNCT00190593Phase 3
- AFTER: Altering Fat Through Estrogen and RaloxifeneCompletedNCT00149604Phase 2
- Effects of Teriparatide in Postmenopausal Women With OsteoporosisCompletedNCT00079924Phase 4
- Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's DiseaseCompletedNCT00065767Phase 2/3
- Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With OsteoporosisCompletedNCT00046137Phase 3
- Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00035256Phase 4
- Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast CancerCompletedNCT00031850Not applicable
- Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast CancerCompletedNCT00031811Not applicable
- Raloxifene in Preventing Breast Cancer in Premenopausal WomenCompletedNCT00019500Phase 2
- Raloxifene in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT00004915Phase 2
- Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenCompletedNCT00003906Phase 3
- The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by EndometriosisCompletedNCT00001848Phase 2